NIH-funded research R01 grant

Improving newborn syphilis testing

Official title: Modernizing Perinatal Syphilis Testing

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11241983 · Data updated 2026-11-12

This project will use newer lab tests on mothers and newborns to find syphilis earlier so babies can get treatment sooner.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startDecember 21, 2022
Project endNovember 30, 2027
Funding year2026
Award (this year)$654,908
NIH project number5R01HD108201-04
Project IDNIH-11241983 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people with positive or uncertain syphilis test results or other risk factors and their newborns who deliver at participating hospitals are the intended candidates.

Less likely to help

People without maternal syphilis exposure or newborns already clearly uninfected are unlikely to receive direct benefit from participation.

What this research studies

If you join, researchers will collect samples from you and your newborn at or soon after birth and run modern molecular tests that look directly for the syphilis bacterium. They will enroll about 924 mother–baby pairs at several hospitals and follow the babies over time to see who develops confirmed congenital syphilis. The new tests include real-time qPCR and the Aptima TMA assay and will be compared to the current diagnostic categories used at birth under 2021 guidelines. Doctors will combine these test results with routine clinical follow-up to determine whether the molecular tests identify infection earlier than existing care.

Why it matters

Potential benefit: If successful, these tests could diagnose congenital syphilis at or soon after birth, reducing delayed or missed treatment and preventing avoidable harm.

How similar studies have gone: Early lab and small clinical studies suggest nucleic acid tests can detect Treponema pallidum, but large multicenter clinical validation is still limited.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Stafford, Irene a. — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Stafford, Irene a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.